1. Meeting and attendance
(1) The convening of the meeting
1. Meeting time: May 13, 2021
2. Meeting place: company meeting room
3. Meeting method: on-site
4. Convener of the meeting: Board of Directors
5. Moderator of the meeting: Chairman Wang Xueliang
6. Explanation of legality, compliance, and constitutionality of the convening situation:
The procedures for convening, convening, and reviewing proposals are in compliance with the "Company Law" and "Articles of Association" and the relevant provisions of the company's management system on the convening of general meetings of shareholders, and the resolutions made are legal and valid.

(2) Meeting attendance
A total of 14 shareholders attended and authorized to attend this general meeting, with a total of 117,953,400 voting shares, accounting for 93.61% of the company's total voting shares.

(3) The company's directors, supervisors, and senior management personnel attending or attending the general meeting of shareholders as non-voting delegates
1. There are 7 incumbent directors of the company and 7 people attended;
2. There are 3 current supervisors of the company and 3 people are present;
3. The secretary of the company's board of directors attended the meeting;
Senior executives of the company Wang Xueliang, Yuan Zhao, Zhang Wei, Zhao Junling, Tao Xu, Cai Liying, Qu Shen, and Chen Hongquan attended the meeting as non-voting delegates.

2. Review of the proposal
(1) Examined and approved the "2020 Annual Report and its Summary"
1. The content of the proposal:
The report has been disclosed in the "Annual Report 2020" (Announcement No.: 2021-011) and the "Summary of the 2020 Annual Report" (Announcement Number: 2021-012).
2. The result of the voting on the proposal:
117,953,400 shares approved, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for this general meeting of shareholders 0% of the total number of voting shares.
3. Avoid voting
This proposal does not involve related matters, and there is no situation in which voting should be avoided.

(2) Examined and approved the "Special Report on Capital Occupation in 2020"
1. The content of the proposal:
The report has been disclosed in the "Special Report on Capital Occupation for 2020" (Announcement No.: 2021-016) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn).
2. The result of the voting on the proposal:
117,953,400 shares approved, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for this general meeting of shareholders 0% of the total number of voting shares.
3. Avoid voting
This proposal does not involve related matters, and there is no situation in which voting should be avoided.

(3) Examined and approved the "2020 Board of Directors Work Report"
1. The content of the proposal:
The company's board of directors reviewed and discussed the work in 2020, and formed the work report of the board of directors in 2020.
2. The result of the voting on the proposal:
117,953,400 shares approved, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for this general meeting of shareholders 0% of the total number of voting shares.
3. Avoid voting
This proposal does not involve related matters, and there is no situation in which voting should be avoided.

(4) Examined and approved the "2020 Work Report of the Board of Supervisors"
1. The content of the proposal:
The company's board of supervisors reviewed and discussed the work in 2020, and formed the work report of the board of supervisors in 2020.
2. The result of the voting on the proposal:
117,953,400 shares approved, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for this general meeting of shareholders 0% of the total number of voting shares.
3. Avoid voting
This proposal does not involve related matters, and there is no situation in which voting should be avoided.

(5) Examined and approved the "2020 Financial Final Account Report"
1. The content of the proposal:
The company has summarized the company's 2020 financial status based on the actual situation, and made a 2020 financial statement report.
2. The result of the voting on the proposal:
117,953,400 shares approved, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for this general meeting of shareholders 0% of the total number of voting shares.
3. Avoid voting
This proposal does not involve related matters, and there is no situation in which voting should be avoided.

(6) Examined and approved the "2021 Financial Budget Report"
1. The content of the proposal:
According to the company's 2020 financial statement report and the company's actual situation and subsequent development, the company has formulated the 2021 financial budget.
2. The result of the voting on the proposal:
117,953,400 shares approved, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for this general meeting of shareholders 0% of the total number of voting shares.
3. Avoid voting
This proposal does not involve related matters, and there is no situation in which voting should be avoided.

(7) Examined and approved the "2020 Profit Distribution Plan"
1. The content of the proposal:
According to the company's operating conditions and the "audit report" issued by Lixin Certified Public Accountants (special general partnership), for the long-term development of the company, no profit distribution will be made in 2020.
2. The result of the voting on the proposal:
117,953,400 shares approved, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for this general meeting of shareholders 0% of the total number of voting shares.
3. Avoid voting
This proposal does not involve related matters, and there is no situation in which voting should be avoided.

(8) Examined and approved the "Regarding the Renewal of the Appointment of Audit Institutions for 2021"
1. The content of the proposal:
The report has been disclosed in the "Announcement of Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.'s Proposal to Renew the Appointment of an Accounting Firm" (Announcement No.: 2021-019) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn) .
2. The result of the voting on the proposal:
117,953,400 shares approved, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for this general meeting of shareholders 0% of the total number of voting shares.
3. Avoid voting
This proposal does not involve related matters, and there is no situation in which voting should be avoided.

3. Attorney Witness
(1) Law firm name: DeHeng Shanghai Law Firm
(2) Lawyer's name: Hu Haotian, Tang Sijie
(3) Concluding observations
Our lawyers believe that the convening and convening procedures of this shareholders meeting, the qualifications of attending the meeting, the proposals and voting procedures of this shareholders meeting, etc. are in compliance with the "Company Law", "Securities Law" and other laws, regulations, and regulatory documents In accordance with the relevant provisions of the "Articles of Association" and "Rules of Procedure of the General Meeting of Shareholders", the resolutions passed by this general meeting of shareholders are legal and valid.

4. List of available documents
1. Resolutions and minutes of the 2020 annual general meeting of shareholders of Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.

Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.
Board of Directors
May 14 2021